India Pharma Outlook’s June Edition - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.
“ARR Molecules continues to strengthen its research and development capabilities while investing in advanced analytical systems and process improvement initiatives” - ARR Molecules
“CHROMQ provides NABL-traceable calibration support and reference standards that help laboratories maintain testing accuracy and audit readiness” – CHROMQ India
“By integrating ethical compliance with patient-focused execution, CRO Pharmatrendz aims to improve both participant retention and overall study quality — two factors that are increasingly critical in complex oncology research environments” - CRO Pharmatrendz
“Dhanvantari Clinical Research Solutions is actively adopting decentralized and patient-friendly trial approaches to improve engagement and retention” - Dhanvantari Clinical Research Solutions
“PHARMANALYTICA’s product opportunity mapping and competitive intelligence services are designed to help companies uncover...
Our subscribers play a decisive role in finalization of our annual list of Industry of the year Vol.II - 2026 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
 |  | ARR Molecules | The global pharmaceutical industry is undergoing a major transformation as pharmaceutical companies increasingly rely on Contract Development and Manufacturing Organizations (CRDMOs) to accelerate drug development. |
 |  | CHROMQ Instruments | India’s pharmaceutical industry is entering a new era de¬fined not just by manufacturing scale, but by precision, compliance, and research-driven innovation. |
 |  | CRO Pharmatrendz | Cancer research is undergoing a major transformation with the rise of precision medicine, biomarker-driven therapies, immuno-oncology, and targeted treatments. |
 |  | PHARMANALYTICA | The pharmaceutical industry is entering a new era of transformation, where scientific innovation, regulatory complexity, and evolving patient expectations are redefining the way companies approach growth. |
